FDA Inspection 1090151 — SPI Pharma, Inc.
The FDA completed an inspection of SPI Pharma, Inc. on April 29, 2019 in Grand Haven, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 29, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Grand Haven, MI (United States)